BofA lowered the firm’s price target on Albertsons (ACI) to $20 from $22 and keeps a Neutral rating on the shares. Q3 sales and earnings were helped by pharmacy and digital growth, notes the analyst, who lowered the firm’s FY26 adjusted EPS estimate to $2.12 in line with the company’s updated guidance of $2.08-$2.16.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACI:
- Albertsons price target lowered to $22 from $24 at Telsey Advisory
- Albertsons resumed with a Hold at Deutsche Bank
- Albertsons price target lowered to $23 from $25 at UBS
- Albertsons price target lowered to $23 from $25 at BMO Capital
- Albertsons: Resilient Earnings, Disciplined Pricing, and Attractive Valuation Support Buy Rating